Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Bizily currently holds 58,066 shares of 4D Molecular Therapeutics, Inc. (FDMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Bizily has been a net seller of FDMT stock. They have purchased $0 and sold $1.7M worth of shares.
Scott Bizily's most recent insider trade was on Sep 16, 2026, when they sold 1,635 shares at $0.00 per share.
Scott Bizily serves as Executive at 4D Molecular Therapeutics, Inc. (FDMT). They have executed 112 insider transactions totaling $1.7M over their tenure at the company.
Scott Bizily holds the position of Executive at 4D Molecular Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Scott Bizily has shown a selling trading pattern, with $0 in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott Bizily was on Jul 1, 2024, when they sold $90.7K worth of FDMT shares. This transaction involved 4,248 shares at $21.36 per share.
Scott Bizily currently owns 58,066 shares of 4D Molecular Therapeutics, Inc. (FDMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Bizily's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Bizily has 112 Form 4 filings on record as an insider at 4D Molecular Therapeutics, Inc..
Set alerts for Scott Bizily and 40,000+ other insiders.